Dr. Michael W. Craige is a research scientist and fellow, leveraging his expertise in biomedical informatics, data science, intellectual property law, and innovation strategy to assess patent, and license new inventions and technologies reported by scientists. He has contributed to publications in high-impact journals, such as Nature Communications and Frontiers in Oncology, and has helped several startups secure their first institutional venture capital funding. His professional journey encompasses a rich blend of roles, including an NSF I-Corps Startup Mentor at Rutgers Office of Innovation Ventures, his recent tenure as a Venture Capital Fellow at SOSV's IndieBio in New York, and training in intellectual property law as a patent agent at Casimir Jones Law Firm. Dr. Craige received his MBA from The Georgia Institute of Technology and his PhD in Biomedical Informatics at Rutgers University where he’s developing computational methods for high-throughput cancer genomic data analysis, including statistical models for elucidating the mechanisms of prostate cancer disease progression and therapeutic response. During his doctoral program, he focused his research on pediatric neurology to understand the underline molecular mechanism of epilepsy in infants, jointly at Emory and Rutgers University. Dr. Craige was the managing director and ex-founder at CiDrep Informatics, a health and scientific-informatics consulting firm, that operated across the US and Canada.